{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:15:15Z","timestamp":1779905715528,"version":"3.53.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["Linea 2_CLOCA_AA_2017 \u201cAldosterone in cardiac and renal diseases in dogs\u201d"],"award-info":[{"award-number":["Linea 2_CLOCA_AA_2017 \u201cAldosterone in cardiac and renal diseases in dogs\u201d"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic renin-angiotensin-aldosterone system (RAAS) activation in course of heart diseases contributes to cardiac remodeling and heart failure. Myxomatous mitral valve disease (MMVD) is characterized by different stages of severity and trend of RAAS activity during the course of the disease is still uncertain. The urinary aldosterone-to-creatinine ratio (UAldo:C) has been proven to reflect RAAS activation in dogs and might be a useful marker in monitoring therapy and disease progression, but data about this parameter need to be expanded. The objective of this study was to evaluate the UAldo:C in healthy dogs and dogs with naturally occurring MMVD, and to investigate the relationships between this parameter and clinical, echocardiographic and laboratory variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study population consisted of 149 dogs: 49 healthy and 100 MMVD dogs (45 stage B1, 13 stage B2 and 42 stage C). Urinary aldosterone-to-creatinine ratio was not significantly different among healthy and MMVD dogs of any stages. Breed, sex and age showed a significant impact on UAldo:C. In particular, Chihuahua and Cavalier King Charles spaniel showed significantly higher UAldo:C than other breeds, as well as intact females than other genders. In stage C dogs, UAldo:C appeared to be increased by spironolactone and was positively associated with furosemide dose (<jats:italic>P<\/jats:italic>\u2009=\u20090.024). Aldosterone breakthrough (ABT) appeared to occur in 36% (8\/22) of stage C dogs not receiving spironolactone. A significant positive association between UAldo:C and left atrium-to-aortic root\u00a0ratio (LA\/Ao) was found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Individual factors such as breed, sex and age appeared to influence UAldo:C, and therapy seemed to add further variability. In the light of these results, comparing the UAldo:C of a single patient with a population-based reference value might lead to wrong interpretations and an individual monitoring should be considered. The prevalence of ABT in the present study (36%) was in line with those previously reported. However, due to the high individual variability of UAldo:C found in the study, even this result should be re-evaluated in the setting of an individual longitudinal approach. The positive association between UAldo:C and LA\/Ao supports the mutual relationship between RAAS and cardiac remodeling.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-020-02716-6","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T14:03:57Z","timestamp":1610028237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-4089","authenticated-orcid":false,"given":"Alberto","family":"Galizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Bagardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Stranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Zanaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Malchiodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliano","family":"Borromeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Giuseppina","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"2","key":"2716_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/jvim.15454","volume":"33","author":"MK Ames","year":"2019","unstructured":"Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33(2):363\u201382.","journal-title":"J Vet Intern Med."},{"key":"2716_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cvsm.2004.05.005","volume":"34","author":"DD Sisson","year":"2004","unstructured":"Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin Small Anim. 2004;34:1105\u201326.","journal-title":"Vet Clin Small Anim"},{"key":"2716_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50:89\u201399.","journal-title":"J Vasc Res"},{"key":"2716_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","volume":"17","author":"KC Gilbert","year":"2010","unstructured":"Gilbert KC, Brown NJ. Aldosterone and inflammation. Curr Op Endocrinol Diabetes Obes. 2010;17:199\u2013204.","journal-title":"Curr Op Endocrinol Diabetes Obes"},{"key":"2716_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMra000050","volume":"345","author":"KT Weber","year":"2001","unstructured":"Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001;345:1689\u201397.","journal-title":"N Engl J Med"},{"key":"2716_CR6","doi-asserted-by":"crossref","unstructured":"Brilla CG, Rupp H, Funck R, Maisch B. The renin-angiotensin aldosterone system and myocardial collagen matrix remodeling in congestive heart failure. Eur Heart J. 1995;16(Suppl O):107\u20139.","DOI":"10.1093\/eurheartj\/16.suppl_O.107"},{"key":"2716_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","volume":"61","author":"AD Struthers","year":"2004","unstructured":"Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res. 2004;61:663\u201370.","journal-title":"Cardiovasc Res"},{"key":"2716_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/ASN.2007101079","volume":"19","author":"G Remuzzi","year":"2008","unstructured":"Remuzzi G, Cattaneo D, Perico N. The aggravating mechanisms of aldosterone on kidney fibrosis. Am Soc Nephrol. 2008;19:1459\u201362.","journal-title":"Am Soc Nephrol"},{"key":"2716_CR9","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1161\/CIRCULATIONAHA.108.817411","volume":"118","author":"RS Velagaleti","year":"2008","unstructured":"Velagaleti RS, Gona P, Levy D, et al. Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation. 2008;118:2252\u20138.","journal-title":"Circulation."},{"key":"2716_CR10","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1161\/CIRCULATIONAHA.111.067918","volume":"124","author":"JA Leopold","year":"2011","unstructured":"Leopold JA. Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling. Circulation. 2011;124:e466\u20138.","journal-title":"Circulation."},{"key":"2716_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1055\/s-0035-1565055","volume":"47","author":"C Catena","year":"2015","unstructured":"Catena C, Colussi G, Brosolo G, et al. Aldosterone and left ventricular remodeling. Horm Metab Res. 2015;47:981\u20136.","journal-title":"Horm Metab Res"},{"key":"2716_CR12","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1097\/HJH.0000000000002146","volume":"37","author":"W Dian","year":"2019","unstructured":"Dian W, Jian-Zhong X, Xin C, et al. Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography. J Hypertens. 2019;37:2032\u201340.","journal-title":"J Hypertens"},{"key":"2716_CR13","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.ijchy.2019.100015","volume":"2","author":"S Zhang","year":"2019","unstructured":"Zhang S, Gao X, Wang D, et al. Association between elevated plasma aldosterone concentration and left atrial conduit function in hypertension. Int J Cardiol Hypertens. 2019;2:100015.","journal-title":"Int J Cardiol Hypertens"},{"key":"2716_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","volume":"115","author":"G G\u00fcder","year":"2007","unstructured":"G\u00fcder G, Bauersachs J, Frantz S, et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation. 2007;115:1754\u201361.","journal-title":"Circulation."},{"key":"2716_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurjhf\/hft100","volume":"15","author":"N Girerd","year":"2013","unstructured":"Girerd N, Pang PS, Swedberg K, et al. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial. Eur J Heart Fail. 2013;15:1228\u201335.","journal-title":"Eur J Heart Fail"},{"key":"2716_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ahj.2008.12.013","volume":"157","author":"F Beygui","year":"2009","unstructured":"Beygui F, Montalescot G, Vicaut E, et al. Aldosterone and long-term outcome after myocardial infarction: a substudy of the french nationwide Observatoire Sur la prise en charge hospitali\u00e8re, l'Evolution \u00e0 un an et les caract\u00e9ristiques de patients pr\u00e9sentant un infarctus du myocarde avec ou sans onde Q (OPERA) study. Am Heart J. 2009;157:680\u20137.","journal-title":"Am Heart J"},{"key":"2716_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2460\/ajvr.73.11.1765","volume":"73","author":"MJ Hezzell","year":"2012","unstructured":"Hezzell MJ, Boswood A, Chang YM, et al. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease. Am J Vet Res. 2012;73:1765\u201374.","journal-title":"Am J Vet Res"},{"key":"2716_CR18","first-page":"672","volume":"24","author":"MJ Hezzell","year":"2010","unstructured":"Hezzell MJ, Boswood A, Elliott J. Relationships between serum and urinary aldosterone, ventricular remodeling and outcome in dogs with mitral valve disease. J Vet Intern MedAbstract ACVIM FORUM 2010. 2010;24:672.","journal-title":"J Vet Intern Med"},{"key":"2716_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:710\u20137.","journal-title":"N Engl J Med"},{"key":"2716_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","volume":"24","author":"F Bernay","year":"2010","unstructured":"Bernay F, Bland JM, H\u00e4ggstr\u00f6m J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med. 2010;24:331\u201341.","journal-title":"J Vet Intern Med"},{"key":"2716_CR21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450\u20136.","journal-title":"JAMA."},{"key":"2716_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","volume":"1","author":"BENCH (BENazepril in Canine Heart Disease) Study Group","year":"1999","unstructured":"BENCH (BENazepril in Canine Heart Disease) Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol. 1999;1:7\u201318.","journal-title":"J Vet Cardiol"},{"key":"2716_CR23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Kenee","year":"2019","unstructured":"Kenee BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127\u201340.","journal-title":"J Vet Intern Med"},{"key":"2716_CR24","first-page":"991","volume":"183","author":"GG Knowlen","year":"1983","unstructured":"Knowlen GG, Kittleson MD, Nachreiner NF, et al. Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure. J Am Vet Med Assoc. 1983;183:991\u20136.","journal-title":"J Am Vet Med Assoc"},{"key":"2716_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","volume":"62","author":"A Tidholm","year":"2001","unstructured":"Tidholm A, H\u00e4ggstr\u00f6m J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res. 2001;62:961\u20137.","journal-title":"Am J Vet Res"},{"key":"2716_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0034-5288(95)90055-1","volume":"59","author":"J Koch","year":"1995","unstructured":"Koch J, Pedersen HD, Jensen AL. Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci. 1995;59:172\u20135.","journal-title":"Res Vet Sci"},{"key":"2716_CR27","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/jvim.15548","volume":"33","author":"E Larouche-Lebel","year":"2019","unstructured":"Larouche-Lebel E, Loughran KA, Oyama MA, et al. Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease. J Vet Intern Med. 2019;33:1571\u201384.","journal-title":"J Vet Intern Med"},{"key":"2716_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1939-1676.1995.tb01092.x","volume":"9","author":"HD Pedersen","year":"1995","unstructured":"Pedersen HD, Koch J, Poulsen K, et al. Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med. 1995;9:328\u201331.","journal-title":"J Vet Intern Med"},{"key":"2716_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/BF03548123","volume":"37","author":"HD Pedersen","year":"1996","unstructured":"Pedersen HD. Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs. Acta Vet Scand. 1996;37:109\u201318.","journal-title":"Acta Vet Scand"},{"issue":"6 Pt 2","key":"2716_CR30","first-page":"H2065","volume":"269","author":"LJ Dell\u2019Italia","year":"1995","unstructured":"Dell\u2019Italia LJ, Meng QC, Balcells E, et al. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol. 1995;269(6 Pt 2):H2065\u201373.","journal-title":"Am J Physiol"},{"key":"2716_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2460\/ajvr.1997.58.01.77","volume":"58","author":"J H\u00e4ggstr\u00f6m","year":"1997","unstructured":"H\u00e4ggstr\u00f6m J, Hansson K, Kvart C, et al. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res. 1997;58:77\u201382.","journal-title":"Am J Vet Res"},{"issue":"1","key":"2716_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/rvsc.1998.0232","volume":"66","author":"HD Pedersen","year":"1999","unstructured":"Pedersen HD, Olsen LH. Neuroendocrine changes in dachshunds with mitral valve prolapse examined under different study conditions. Res Vet Sci. 1999;66(1):11\u20137.","journal-title":"Res Vet Sci."},{"key":"2716_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2460\/ajvr.68.10.1045","volume":"68","author":"Y Fujii","year":"2007","unstructured":"Fujii Y, Orito K, Muto M, et al. Modulation of the tissue renin-angiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve. Am J Vet Res. 2007;68:1045\u201350.","journal-title":"Am J Vet Res"},{"issue":"1","key":"2716_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jvim.15662","volume":"34","author":"D Adin","year":"2020","unstructured":"Adin D, Kurtz K, Atkins C, et al. Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease. J Vet Intern Med. 2020;34(1):53\u201364.","journal-title":"J Vet Intern Med."},{"key":"2716_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jvc.2019.12.002","volume":"27","author":"M Borgarelli","year":"2020","unstructured":"Borgarelli M, Ferasin L, Lamb K, et al. DELay of appearance of symptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril: the DELAY study. J Vet Cardiol. 2020;27:34\u201353.","journal-title":"J Vet Cardiol"},{"key":"2716_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1939-1676.2007.tb02933.x","volume":"21","author":"M Lynne O\u2019Sullivan","year":"2007","unstructured":"Lynne O\u2019Sullivan M, O\u2019Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal doberman pinschers and doberman pinschers with dilated cardiomyopathy. J Vet Intern Med. 2007;21:92\u20139.","journal-title":"J Vet Intern Med"},{"key":"2716_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough. Nat Rev Nephrol. 2007;3:486\u201392.","journal-title":"Nat Rev Nephrol"},{"key":"2716_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jvc.2017.03.001","volume":"19","author":"MK Ames","year":"2017","unstructured":"Ames MK, Atkins CE, Eriksson A, et al. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease. J Vet Cardiol. 2017;19:218\u201327.","journal-title":"J Vet Cardiol"},{"key":"2716_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvc.2006.11.001","volume":"9","author":"SY Gardner","year":"2007","unstructured":"Gardner SY, Atkins CE, Rausch WP, et al. Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio. J Vet Cardiol. 2007;9:1\u20137.","journal-title":"J Vet Cardiol"},{"key":"2716_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1470320316633897","volume":"17","author":"MK Ames","year":"2016","unstructured":"Ames MK, Atkins CE, Lantis AC, et al. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition. J Renin Angiotensin Aldosterone Syst. 2016;17:1\u201312.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2716_CR41","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2460\/ajvr.72.12.1646","volume":"72","author":"AC Lantis","year":"2011","unstructured":"Lantis AC, Atkins CE, DeFrancesco TC, et al. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating reninangiotensin- aldosterone system in clinically normal dogs. Am J Vet Res. 2011;72:1646\u201351.","journal-title":"Am J Vet Res"},{"key":"2716_CR42","first-page":"1084","volume":"74","author":"MK Ames","year":"2013","unstructured":"Ames MK, Atkins CE, Lantis AC, et al. Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs. J Am Vet Med Assoc. 2013;74:1084\u201390.","journal-title":"J Am Vet Med Assoc"},{"key":"2716_CR43","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1939-1676.2009.0367.x","volume":"23","author":"MB Sayer","year":"2009","unstructured":"Sayer MB, Atkins CE, Fujii Y, et al. Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs. J Vet Intern Med. 2009;23:1003\u20136.","journal-title":"J Vet Intern Med"},{"key":"2716_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2460\/ajvr.2001.62.1793","volume":"62","author":"CS Lovern","year":"2001","unstructured":"Lovern CS, Swecker WS, Lee JC, et al. Additive effects of a sodium chloride restricted diet and furosemide administration in healthy dogs. Am J Vet Res. 2001;62:1793\u20136.","journal-title":"Am J Vet Res"},{"key":"2716_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2005.02.016","volume":"106","author":"RMA Van de Wal","year":"2006","unstructured":"Van de Wal RMA, Plokker HWM, Lok DJA, et al. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol. 2006;106:367\u201372.","journal-title":"Int J Cardiol"},{"key":"2716_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1439-0442.1995.tb00397.x","volume":"42","author":"HD Pedersen","year":"1995","unstructured":"Pedersen HD, Olsen LH, Arnorsdottir H. Breed differences in the plasma renin activity and plasma aldosterone concentration of dogs. J Vet Med A. 1995;42:435\u201341.","journal-title":"J Vet Med A"},{"key":"2716_CR47","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jvim.15746","volume":"34","author":"D Adin","year":"2020","unstructured":"Adin D, Atkins C, Domenig O, et al. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism. J Vet Intern Med. 2020;34:600\u20136.","journal-title":"J Vet Intern Med"},{"key":"2716_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/FPC.0000000000000322","volume":"28","author":"KM Meurs","year":"2018","unstructured":"Meurs KM, Olsen LH, Reimann MJ, et al. Angiotensin-converting enzyme activity in cavalier king charles spaniels with an ACE gene polymorphism and myxomatous mitral valve disease. Pharmacogenet Genomics. 2018;28:37\u201340.","journal-title":"Pharmacogenet Genomics"},{"key":"2716_CR49","doi-asserted-by":"publisher","first-page":"147032031773718","DOI":"10.1177\/1470320317737184","volume":"18","author":"KM Meurs","year":"2017","unstructured":"Meurs KM, Stern JA, Atkins CE, et al. Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism. J Renin Angiotensin Aldosterone Syst. 2017;18:1470320317737184.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2716_CR50","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","volume":"37","author":"M Cicoira","year":"2001","unstructured":"Cicoira M, Zanolla L, Rossi A, et al. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol. 2001;37:1808\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"2716_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.HYP.34.3.423","volume":"34","author":"F Paillard","year":"1999","unstructured":"Paillard F, Chansel D, Brand E, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension. 1999;34:423\u20139.","journal-title":"Hypertension."},{"key":"2716_CR52","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/GIM.0b013e3181809613","volume":"10","author":"AK Motti","year":"2008","unstructured":"Motti AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med. 2008;10:560\u201374.","journal-title":"Genet Med"},{"key":"2716_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9149(96)00296-2","volume":"78","author":"A Pfeufer","year":"1996","unstructured":"Pfeufer A, Osterziel KJ, Urata H, et al. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol. 1996;78:362\u20134.","journal-title":"Am J Cardiol"},{"key":"2716_CR54","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ejhg.2012.48","volume":"20","author":"ICRM Kolder","year":"2012","unstructured":"Kolder ICRM, Michels M, Christiaans I, et al. The role of renin\u2013angiotensin\u2013aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy. Eur J Hum Genet. 2012;20:1071\u20137.","journal-title":"Eur J Hum Genet"},{"key":"2716_CR55","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1210\/jcem.87.4.8406","volume":"87","author":"N Hirshoren","year":"2002","unstructured":"Hirshoren N, Tzoran I, Makrienko I, et al. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab. 2002;87:1569\u201375.","journal-title":"J Clin Endocrinol Metab"},{"key":"2716_CR56","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1210\/jc.2006-1154","volume":"91","author":"ED Szmuilowicz","year":"2006","unstructured":"Szmuilowicz ED, Adler GK, Williams JS, et al. Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab. 2006;91:3981\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2716_CR57","doi-asserted-by":"crossref","unstructured":"Mihailidou AS, Ashton AW. Cardiac effects of aldosterone: does gender matter?. Steroids. 2014;91:32\u20137.","DOI":"10.1016\/j.steroids.2014.08.013"},{"key":"2716_CR58","first-page":"E601","volume":"270","author":"K Myles","year":"1996","unstructured":"Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am J Physiol. 1996;270:E601\u20137.","journal-title":"Am J Physiol"},{"key":"2716_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0922-4106(93)90072-H","volume":"247","author":"R Rupprecht","year":"1993","unstructured":"Rupprecht R, Reul JM, van Steensel B, et al. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993;247:145\u201354.","journal-title":"Eur J Pharmacol"},{"key":"2716_CR60","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1210\/endo.137.11.8895346","volume":"137","author":"LM Braley","year":"1996","unstructured":"Braley LM, Menachery AI, Yao T, et al. Effect of progesterone on aldosterone secretion in rats. Endocrinology. 1996;137:4773\u20138.","journal-title":"Endocrinology."},{"key":"2716_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1681\/ASN.V132446","volume":"13","author":"M Chidambaram","year":"2002","unstructured":"Chidambaram M, Duncan JA, Lai VS, et al. Variation in the renin angiotensin system through the normal menstrual cycle. J Am Soc Nephrol. 2002;13:446\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"2716_CR62","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","volume":"24","author":"K Komukai","year":"2010","unstructured":"Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. 2010;24:687\u20139.","journal-title":"Fundam Clin Pharmacol"},{"key":"2716_CR63","doi-asserted-by":"publisher","first-page":"R498","DOI":"10.1152\/ajpregu.00182.2014","volume":"307","author":"E O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell E, Floras JS, Harvey PJ. Estrogen status and the renin angiotensin aldosterone system. Am J Physiol Regul Integr Comp Physiol. 2014;307:R498\u2013500.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2716_CR64","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:672\u20137.","journal-title":"Cardiovasc Res"},{"key":"2716_CR65","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1007\/s11033-012-2446-6","volume":"40","author":"SK Sia","year":"2013","unstructured":"Sia SK, Chiou HL, Chen SC, et al. Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population. Mol Biol Rep. 2013;40:3705\u201311.","journal-title":"Mol Biol Rep"},{"key":"2716_CR66","doi-asserted-by":"publisher","first-page":"538053","DOI":"10.1155\/2014\/538053","volume":"2014","author":"K Dhanachandra Singh","year":"2014","unstructured":"Dhanachandra Singh K, Jajodia A, Kaur H, et al. Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study. Biomed Res Int. 2014;2014:538053.","journal-title":"Biomed Res Int"},{"key":"2716_CR67","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1046\/j.1523-1755.2002.00624.x","volume":"62","author":"GL Schwartz","year":"2002","unstructured":"Schwartz GL, Turner ST, Chapman AB, et al. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int. 2002;62:1718\u201323.","journal-title":"Kidney Int"},{"key":"2716_CR68","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/01.HYP.37.3.875","volume":"37","author":"AA Sethi","year":"2001","unstructured":"Sethi AA, Nordestgaard BG, Agerholm-Larsen B, et al. Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen city heart study. Hypertension. 2001;37:875\u201381.","journal-title":"Hypertension."},{"key":"2716_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2165\/00002512-199303030-00005","volume":"3","author":"JH Bauer","year":"1993","unstructured":"Bauer JH. Age-related changes in the renin aldosterone system. Physiological effects and clinical implications. Drugs Aging. 1993;3:238\u201345.","journal-title":"Drugs Aging"},{"key":"2716_CR70","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/CIRCULATIONAHA.117.029421","volume":"136","author":"JW Funder","year":"2017","unstructured":"Funder JW. Aldosterone in advancing age: don\u2019t\u2019 shoot the messenger. Circulation. 2017;136:356\u20138.","journal-title":"Circulation."},{"key":"2716_CR71","first-page":"425","volume":"47","author":"MM Kau","year":"1999","unstructured":"Kau MM, Chen JJ, Wang SW, et al. Age-related impairment of aldosterone secretion in zona glomerulosa cells of ovariectomized rats. J Invest Med. 1999;47:425\u201332.","journal-title":"J Invest Med"},{"issue":"5 Pt 2","key":"2716_CR72","first-page":"R833","volume":"264","author":"B Jover","year":"1993","unstructured":"Jover B, Dupont M, Geelen G, et al. Renal and systemic adaptation to sodium restriction in aging rats. Am J Physiol. 1993;264(5 Pt 2):R833\u20138.","journal-title":"Am J Physiol"},{"key":"2716_CR73","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.117.10391","volume":"71","author":"K Nanba","year":"2018","unstructured":"Nanba K, Vaidya A, Rainey WE, et al. Aging and adrenal aldosterone production. Hypertension. 2018;71:218\u201323.","journal-title":"Hypertension."},{"key":"2716_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.rvsc.2006.07.010","volume":"82","author":"I Goy-Thollot","year":"2007","unstructured":"Goy-Thollot I, Decosne-Junot C, Bonnet JM. Influence of aging on adrenal responsiveness in a population of eleven healthy beagles. Res Vet Sci. 2007;82:195\u2013201.","journal-title":"Res Vet Sci"},{"key":"2716_CR75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/0895-7061(96)00022-2","volume":"9","author":"P Trenkwalder","year":"1996","unstructured":"Trenkwalder P, James GD, Laragh JH, et al. Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age. Am J Hypertens. 1996;9:621\u20137.","journal-title":"Am J Hypertens"},{"key":"2716_CR76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1532-5415.1980.tb00521.x","volume":"28","author":"T Saruta","year":"1980","unstructured":"Saruta T, Suzuki A, Hayashi M, et al. Mechanism of age-related changes in renin and adrenocortical steroids. J Am Geriatr Soc. 1980;28:210\u20134.","journal-title":"J Am Geriatr Soc"},{"key":"2716_CR77","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","volume":"136","author":"K Nanba","year":"2017","unstructured":"Nanba K, Vaidya A, Williams GH, et al. Age-related autonomous aldosteronism. Circulation. 2017;136:347\u201355.","journal-title":"Circulation."},{"issue":"12","key":"2716_CR78","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2460\/ajvr.76.12.1041","volume":"76","author":"MK Ames","year":"2015","unstructured":"Ames MK, Atkins CE, Lee S, et al. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs. Am J Vet Res. 2015;76(12):1041\u201350.","journal-title":"Am J Vet Res"},{"issue":"1","key":"2716_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jvp.12154","volume":"38","author":"AC Lantis","year":"2015","unstructured":"Lantis AC, Ames MK, Atkins CE, et al. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs. J Vet Pharmacol Ther. 2015;38(1):65\u201373.","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"2716_CR80","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jvp.12216","volume":"38","author":"AC Lantis","year":"2015","unstructured":"Lantis AC, Ames MK, Werre S, et al. The effect of enalapril on furosemide-activated renin\u2013angiotensin\u2013 aldosterone system in healthy dogs. J Vet Pharmacol Ther. 2015;38(5):513\u20137.","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"2716_CR81","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2885.2007.00894.x","volume":"30","author":"CE Atkins","year":"2007","unstructured":"Atkins CE, Rausch WP, Gardner SY, et al. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. J Vet Pharmacol Ther. 2007;30(5):394\u2013400.","journal-title":"J Vet Pharmacol Ther"},{"key":"2716_CR82","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","volume":"30","author":"A Boswood","year":"2016","unstructured":"Boswood A, H\u00e4ggstr\u00f6m J, Gordon SG, et al. Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study\u2014a randomized clinical trial. J Vet Intern Med. 2016;30:1765\u201379.","journal-title":"J Vet Intern Med"},{"key":"2716_CR83","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jvim.14885","volume":"32","author":"A Boswood","year":"2018","unstructured":"Boswood A, Gordon SG, H\u00e4ggstr\u00f6m J, et al. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with preclinical myxomatous mitral valve disease receiving pimobendan or placebo: the EPIC study. J Vet Intern Med. 2018;32:72\u201385.","journal-title":"J Vet Intern Med"},{"key":"2716_CR84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2369-15-44","volume":"15","author":"A Hannemann","year":"2014","unstructured":"Hannemann A, Rettig R, Dittmann K, et al. Aldosterone and glomerular filtration \u2013 observations in the general population. BMC Nephrol. 2014;15:44.","journal-title":"BMC Nephrol"},{"key":"2716_CR85","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","volume":"32","author":"MJ Acierno","year":"2018","unstructured":"Acierno MJ, Brown S, Coleman AE, et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018;32:1803\u201322.","journal-title":"J Vet Intern Med"},{"key":"2716_CR86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","volume":"7","author":"WP Thomas","year":"1993","unstructured":"Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, american college of veterinary internal medicine. J Vet Intern Med. 1993;7:247\u201352.","journal-title":"J Vet Intern Med"},{"key":"2716_CR87","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","volume":"43","author":"K Hansson","year":"2002","unstructured":"Hansson K, H\u00e4ggstr\u00f6m J, Kvart C, et al. Left atrial to aortic root indices using two-dimensional and m-mode echocardiography in cavalier king charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound. 2002;43:568\u201375.","journal-title":"Vet Radiol Ultrasound"},{"key":"2716_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","volume":"18","author":"CC Cornell","year":"2004","unstructured":"Cornell CC, Kittleson MD, Della Torre P, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004;18:311\u201321.","journal-title":"J Vet Intern Med"},{"key":"2716_CR89","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/jvim.12230","volume":"27","author":"S Brown","year":"2013","unstructured":"IRIS Canine GN Study Group Standard Therapy Subgroup, Brown S, Elliott J, Francey T, et al. Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med. 2013;27:S27\u201343.","journal-title":"J Vet Intern Med"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T01:18:53Z","timestamp":1724289533000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02716-6","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the guidelines of the Animal Care and Use Committee of the University of Milan (approval number 2\/2016) and with informed consent of the owners.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}